Allotment of 290000 equity shares pursuant to the conversion of warrants issued on preferential basis, and after receipt of 75% of the exercise price from warrant holder.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Sampre Nutritions Ltd approved the allotment of 2,90,000 equity shares of INR 10 each to promoter Meera Gurbani, following the conversion of equal number of warrants originally issued on 13 November 2024 on a preferential basis. The promoter paid the remaining 75% of the exercise price, i.e., INR 45.375 per warrant, totaling about INR 1.31 crore, at an effective issue price of INR 60.50 per share. With this conversion, all 8,40,000 warrants issued earlier have now been fully converted, leaving zero outstanding warrants. The company's paid-up equity capital rose from 2,15,56,855 shares to 2,18,46,855 shares.
This is the final tranche of a promoter-funded preferential warrant conversion, bringing in about INR 1.31 crore into the company and strengthening the promoter's absolute shareholding. Since the promoter already held equity, her percentage stake actually dipped from 7.73% to 3.76% due to the enlarged capital base, but there are no further dilution events pending from this instrument.